Radoff and Jumana Capital disclosed a joint 7.6% position in Genesco Inc. through a 13D filing this week, marking the second activist engagement in the footwear and apparel retailer's recent history. The stake represents roughly $40 million at current trading levels and triggers the standard Schedule 13D disclosure threshold, signaling intent beyond passive ownership. Genesco closed Thursday at $34.12, down 1.8% on the session, giving the Nashville-based retailer a market capitalization of $522 million.
The filing arrived without a formal letter attached to public record, but market participants familiar with the situation indicate the activists are preparing to push for board representation and operational repositioning. Genesco operates 1,425 retail locations across the Journeys, Johnston & Murphy, and Schuh banners, with trailing-twelve-month revenue of $2.14 billion and EBITDA margins compressed to 5.2% from 7.1% two years prior. The company has faced persistent inventory challenges and category mix issues as teen mall traffic patterns shift and digital conversion rates lag peer benchmarks. Radoff, a value-oriented activist with prior retail turnaround experience, and Jumana Capital, a generalist fund with $180 million in assets under management, appear to be targeting board composition and capital allocation priorities.
The market read is straightforward: Genesco trades at 0.24x sales and 6.8x forward earnings, a valuation that reflects skepticism around management's ability to reverse margin erosion and stabilize same-store sales. The activists likely see asset value in the Johnston & Murphy brand and potential for cost rationalization across the footwear portfolio. Genesco's board currently includes nine directors, with the last refresh occurring in 2022 when the company added two independent members. The activists' entry suggests they believe the board has not moved aggressively enough on either strategic repositioning or capital return, despite the company repurchasing $25 million in stock over the past year. The timing is notable: Genesco's fiscal year ends January 31, and the company is expected to report fourth-quarter earnings in mid-March, giving activists a clean window to build coalition support before the annual meeting cycle begins.
Operators should watch for a formal proxy filing within 45 days if the activists intend to nominate directors for the 2025 annual meeting, typically held in late May or early June. The company's response posture will clarify whether this engagement turns confrontational or whether management preemptively opens dialogue on board composition and operational review. Separately, Genesco's liquidity position bears monitoring: the company carries $98 million in net debt and has a $350 million revolving credit facility with covenants tied to EBITDA performance. Any activist-driven shift toward accelerated capital return or divestitures would need to navigate these constraints.
The last activist engagement in Genesco ended quietly in 2019, when Legion Partners withdrew after the company agreed to explore strategic alternatives for its Lids Sports Group division, which was subsequently sold for $100 million. The current situation carries more weight because the valuation floor has held for eighteen months despite three successive earnings beats, suggesting the market is pricing in structural headwinds rather than cyclical noise.